A very promising tinnitus treatment that has proven to decrease tinnitus severity in chronic tinnitus patients is currently “stuck” between phase 2 and phase 3 clinical trials.

Sulodexide, an anticoagulant drug, significantly reduced tinnitus severity scores in phase 2 clinical trial patients in 2018. This drug was proven to outperform the placebo. (Please see link below for an article about this study.)

As tinnitus sufferers and/or patient advocates, we are determined to push for research that can potentially lead to treatment and/or a cure that will end the needless suffering of thousands, if not millions, of tinnitus sufferers throughout the world.

Please help us kickstart these “forgotten” trials by expediting Phase 3 in this crucial process!

Thank you!

LINK: https://bit.ly/3lo22vd